Document is current
Any future updates will be listed below
-
Authors
Murasato, Yoshinobu
Nakashima, Hitoshi
Sugino, Hiroshi
Arikawa, Masaya
Mori, Fumiaki
Ueda, Yasunori
Matsumura, Keisuke
Abe, Mitsuru
Koizumi, Tomomi
Shimomura, Mitsuhiro
Fujimoto, Kazuteru
Saeki, Takahiro
Imagawa, Shogo
Takenaka, Takashi
Morita, Yukiko
Kashima, Katsuro
Takami, Akira
Ono, Yujiro
Fukae, Atsuki
Yoshida, Hisako
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Clinical Research from the National Hospital Organization in Japan ((Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02), (Heisei 29-EBM [Observational study]-02))
- License Information
-
More Information
Article History
Received: 7 July 2024
Accepted: 10 March 2025
First Online: 19 March 2025
Declarations
:
: Y. Murasato has received research grant from Orbus Neich and lecturer fees from Abbott Medical, Medtronic, Terumo, and Kaneka. Y. Ueda has received research grant from Abbott Medical, Daiichi-Sankyo, Teijin, Japan Lifeline, Orbus Neich, Janssen, Otsuka, Ono, Eli Lilly, Amgen, Novo Nordisk, and Novartis, and lecture fees from Abbott Medical, Kowa, Bayer, Daiichi-Sankyo, Nipro, Takeda, AstraZeneca, Japan Lifeline, Novartis, Ono, Boehringer Ingelheim, PDR Pharma, Kaneka Medix, Mochida, Otsuka, and Amgen. Other authors do not have any conflict of interest.
